-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Abvc Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Abvc Biopharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$977K, a 55.5% increase year-over-year.
- Abvc Biopharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$8.54M, a 22% increase year-over-year.
- Abvc Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$8.22M, a 45.6% increase from 2022.
- Abvc Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$15.1M, a 29.1% decline from 2021.
- Abvc Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$11.7M, a 37.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)